- Home
- HPP vs PRME Comparison
HPP vs PRME Comparison
Compare HPP & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HPP | PRME |
|---|---|---|
| Founded | 1997 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 556.8M | 666.1M |
| IPO Year | 2010 | 2022 |
Fundamental Metrics
Financial Performance| Metric | HPP | PRME |
|---|---|---|
| Price | $10.20 | $4.04 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $18.56 | $6.42 |
| AVG Volume (30 Days) | 1.4M | ★ 3.7M |
| Earning Date | 02-19-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $781,676,000.00 | $5,977,000.00 |
| Revenue This Year | N/A | $111.80 |
| Revenue Next Year | $6.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $9.96 | $1.11 |
| 52 Week High | $24.01 | $6.94 |
Technical Indicators
Market Signals| Indicator | HPP | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 54.50 | 58.09 |
| Support Level | $10.48 | $3.29 |
| Resistance Level | $11.26 | $4.12 |
| Average True Range (ATR) | 0.59 | 0.25 |
| MACD | -0.36 | 0.04 |
| Stochastic Oscillator | 13.20 | 86.93 |
Price Performance
Historical ComparisonAbout HPP Hudson Pacific Properties Inc.
Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.